These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2045928)

  • 1. In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis.
    Israel O; Front D; Hardoff R; Ish-Shalom S; Jerushalmi J; Kolodny GM
    J Nucl Med; 1991 Jun; 32(6):1157-61. PubMed ID: 2045928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis.
    Israel O; Lubushitzky R; Frenkel A; Iosilevsky G; Bettman L; Gips S; Hardoff R; Baron E; Barzilai D; Kolodny GM
    J Nucl Med; 1994 Jul; 35(7):1155-8. PubMed ID: 8014674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and systemic effects of radiation on bone metabolism measured by quantitative SPECT.
    Israel O; Gorenberg M; Frenkel A; Kuten A; Jerushalmi J; Kolodny GM; Front D
    J Nucl Med; 1992 Oct; 33(10):1774-80. PubMed ID: 1403143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of bone loss in patients with primary hyperparathyroidism using quantitative bone SPECT.
    Israel O; Gips S; Lubushitzky R; Bettman L; Iosilevsky G; Hardoff R; Baron E; Daoud D; Kolodny GM; Front D
    J Nucl Med; 1998 Sep; 39(9):1614-7. PubMed ID: 9744354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
    Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
    J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative bone scintigraphy using SPECT.
    Front D; Israel O; Jerushalmi J; Frenkel A; Iosilevsky G; Feinsod M; Kolodny GM
    J Nucl Med; 1989 Feb; 30(2):240-5. PubMed ID: 2786933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
    Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of sacroiliitis using 99mTc-nanocolloid and 99mTc-MDP scintigraphy.
    Yildiz A; Gungor F; Tuncer T; Karayalcin B
    Nucl Med Commun; 2001 Jul; 22(7):785-94. PubMed ID: 11453052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related normal uptake of 99mTc-MDP in the lower spine.
    Sundkvist GM; Lilja B; Mattsson S
    Nuklearmedizin; 1997 Mar; 36(2):52-5. PubMed ID: 9090647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.
    Nakayama K; Fukumoto S; Takeda S; Takeuchi Y; Ishikawa T; Miura M; Hata K; Hane M; Tamura Y; Tanaka Y; Kitaoka M; Obara T; Ogata E; Matsumoto T
    J Clin Endocrinol Metab; 1996 Feb; 81(2):607-11. PubMed ID: 8636276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic calcification in the thyroid gland demonstrated on bone scan in a patient with primary hyperparathyroidism.
    Amico S; Lucas P; Diebold MD; Liehn JC; Petit J; Valeyre J
    J Nucl Med; 1986 Mar; 27(3):373-6. PubMed ID: 3712056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partially reversible osteopenia after surgery for primary hyperparathyroidism.
    Martin P; Bergmann P; Gillet C; Fuss M; Kinnaert P; Corvilain J; van Geertruyden J
    Arch Intern Med; 1986 Apr; 146(4):689-91. PubMed ID: 3963950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of bone turnover by urinary excretion of 99mTc-MDP.
    Thomsen K; Nilas L; Mogensen T; Christiansen C
    Eur J Nucl Med; 1986; 12(7):342-5. PubMed ID: 3792363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
    Peller PJ; Ho VB; Kransdorf MJ
    Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
    Fogelman I; Greig WR; Bessent RG; Boyle IT
    J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-dimensional bone scintigraphy using volume-rendering technique and SPECT.
    Ota T; Yamamoto I; Ohnishi H; Yuh I; Kigami Y; Suzuki T; Yamamura Y; Murata K; Morita R
    J Nucl Med; 1996 Sep; 37(9):1567-70. PubMed ID: 8790220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of bone scintigraphy in secondary (intestinal) hyperparathyroidism].
    Braun W; Heidenreich P; Guth H
    Rofo; 1984 Apr; 140(4):457-63. PubMed ID: 6232181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical note: bone SPECT of the wrist.
    Dubowitz DJ; Miles KA
    Br J Radiol; 1994 Sep; 67(801):890-3. PubMed ID: 7953231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m diphosphonate retention in hyperparathyroidism.
    Heath H
    Ann Intern Med; 1980 Jun; 92(6):873-4. PubMed ID: 7387037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.